Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026
03-Aug-2026 | Source : BSESun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30 2026
Intimation For Receipt Of Requests For Reclassification Of Shareholder Category
27-Jul-2026 | Source : BSEIntimation for Receipt of Request for Reclassification of Shareholder Category
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Jul-2026 | Source : BSENewspaper Advertisement of 21st Annual General Meeting of Company and related information
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Sun Pharma Advanced Research Company Ltd has announced 5:116 rights issue, ex-date: 16 Mar 16